Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Endocrinol., 06 October 2025

Sec. Adrenal Endocrinology

Volume 16 - 2025 | https://doi.org/10.3389/fendo.2025.1715691

Correction: CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance

This article is a correction to:

  1. CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance

    1. Read original article
Patricio H. Contreras*&#x;Patricio H. Contreras1*†Henrik Falhammar,&#x;Henrik Falhammar2,3†
  • 1Reproductive Health Research Institute, Santiago, Chile
  • 2Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden
  • 3Department of Molecular Medicine, Karolinska Institutet, Stockholm, Sweden

A Correction on
CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance

By Contreras PH and Falhammar H (2025). Front. Endocrinol. 16:1647028. doi: 10.3389/fendo.2025.1647028

“Affiliation Reproductive Health Research Institute, Santiago, Chile” was erroneously given as “Reproductive Endocrinology Unit, Santiago, Chile”.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: crinecerfont, atumelnant, leptin resistance, insulin resistance, ACTH inhibitors, hypercortisolism, CRF1 inhibitors

Citation: Contreras PH and Falhammar H (2025) Correction: CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance. Front. Endocrinol. 16:1715691. doi: 10.3389/fendo.2025.1715691

Received: 29 September 2025; Accepted: 30 September 2025;
Published: 06 October 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Contreras and Falhammar. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Patricio H. Contreras, cGF0aG9tZXJvQGdtYWlsLmNvbQ==

†ORCID: Patricio H. Contreras, orcid.org/0000-0002-4258-2454
Henrik Falhammar, orcid.org/0000-0002-5622-6987

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.